CRISPR-edited hepatic organoids as drug screening platform for non-alcoholic fatty liver disease
@article{HBSN115373, author = {Yinhan Wang and Haifeng Xu}, title = {CRISPR-edited hepatic organoids as drug screening platform for non-alcoholic fatty liver disease}, journal = {Hepatobiliary Surgery and Nutrition}, volume = {12}, number = {4}, year = {2023}, keywords = {}, abstract = {}, issn = {2304-389X}, url = {https://hbsn.amegroups.org/article/view/115373} }